Dual association of β-carotene with risk of tobacco-related cancers in a cohort of French women

Journal of the National Cancer Institute

Volumn 97, Issue 18, 2005, Pages 1338-1344

  Touvier, Mathilde ^a   Kesse, Emmanuelle ^a   Clavel Chapelon, Françoise ^a   Boutron Ruault, Marie Christine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; TOBACCO SMOKE; ANTIOXIDANT; CARCINOGEN;

ADULT; ARTICLE; CANCER RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRANCE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SMOKING HABIT; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; CHEMICALLY INDUCED DISORDER; FEEDING BEHAVIOR; LUNG TUMOR; MIDDLE AGED; NEOPLASM; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK; SMOKING;

ADULT; ANTIOXIDANTS; BETA CAROTENE; CARCINOGENS; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; FOOD HABITS; FRANCE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 25144501588     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji276     Document Type: Article

References (40)

1. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX Study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-42.
2. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000; 92:1881-8.
3. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92.
4. Arab L, Steck-Scott S, Bowen P. Participation of lycopene and beta-carotene in carcinogenesis: Defenders, aggressors, or passive bystanders? Epidemiol Rev 2001;23:211-30.
5. Greenwald P. Beta-carotene and lung cancer: A lesson for future chemoprevention investigations? J Natl Cancer Inst 2003;95:E1.
6. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
7. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
8. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: Effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
9. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up. JAMA 2003;290: 476-85.
10. Malila N, Taylor PR, Virtanen MJ, Korhonen P, Huttunen JK, Albanes D, et al. Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland). Cancer Causes Control 2002;13:617-23.
11. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet 2004;364:1219-28.
12. Baron JA, Cole BF, Mott L, Haile R, Grau M, Church TR, et al. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: Results of a randomized trial. J Natl Cancer Inst 2003;95: 717-22.
13. Mannisto S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, van den Brandt PA, et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 2004;13:40-8.
14. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: The Women's Health Study. J Natl Cancer Inst 1999;91:2102-6.
15. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
16. Clavel-Chapelon F, van Liere MJ, Giubout C, Niravong MY, Goulard H, Le Corre C, et al. E3N, a French cohort study on cancer risk factors. E3N Group. Etude Epidemiologique aupres de femmes de l'Education Nationale. Eur J Cancer Prev 1997;6:473-8.
17. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24.
18. Lucas F, Niravong M, Villeminot S, Kaaks R, Clavel-Chapelon F. Estimation of food portion size using photographs: Validity, strengths, weaknesses and recommendations. J Hum Nutr Diet 1995;8:65-74.
19. van Liere MJ, Lucas F, Clavel F, Slimani N, Villeminot S. Relative validity and reproducibility of a French dietary history questionnaire. Int J Epidemiol 1997;26 Suppl 1:S128-S136.
20. Favier JC, Ireland-Ripert J, Toque C, Feinberg M. Répertoire Général des Aliments. Table de composition (Food composition tables) CIQUAL-REGAL. 2nd ed. Paris (France): Tee & Doc Lavoisier and INRA; 1995.
21. Stein CJ, Colditz GA. Modifiable risk factors for cancer. Br J Cancer 2004; 90:299-303.
22. Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, et al. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 2001;10:209-16.
23. Knudsen N, Bulow I, Laurberg P, Perrild H, Ovesen L, Jorgensen T. High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study. J Endocrinol 2002;175:571-6.
24. Block G, Sinha R, Gridley G. Collection of dietary-supplement data and implications for analysis. Am J Clin Nutr 1994;59:232S-9S.
25. Patterson RE, Neuhouser ML, White E, Hunt JR, Kristal AR. Cancer-related behavior of vitamin supplement users. Cancer Epidemiol Biomarkers Prev 1998;7:79-81.
26. Touvier M, Boutron-Ruault MC, Volatier JL, Martin A. Efficacy and safety of regular vitamin and mineral supplement use in France: Results from the ECCA study. Int J Vitam Nutr Res 2005;75:201-9.
27. Nkondjock A, Ghadirian P. Dietary carotenoids and risk of colon cancer: case-control study. Int J Cancer 2004;110:110-6.
28. Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL Jr, Omenn GS, et al. The Beta-Carotene and Retinol Efficacy Trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 2004;96:1743-50.
29. Knudsen VK, Rasmussen LB, Haraldsdottir J, Ovesen L, Bulow I, Knudsen N, et al. Use of dietary supplements in Denmark is associated with health and former smoking. Public Health Nutr 2002;5:463-8.
30. Duffield-Lillico AJ, Begg CB. Reflections on the landmark studies of beta-carotene supplementation. J Natl Cancer Inst 2004;96:1729-31.
31. Russell RM. The enigma of beta-carotene in carcinogenesis: What can be learned from animal studies. J Nutr 2004;134:262S-8S.
32. Welch RW, Turley E, Sweetman SF, Kennedy G, Collins AR, Dunne A, et al. Dietary antioxidant supplementation and DNA damage in smokers and nonsmokers. Nutr Cancer 1999;34:167-72.
33. Lotan R. Lung cancer promotion by beta-carotene and tobacco smoke: relationship to suppression of retinoic acid receptor-beta and increased activator protein-1? J Natl Cancer Inst 1999;91:7-9.
34. Palozza P, Serini S, Di Nicuolo F, Piccioni E, Calviello G. Prooxidant effects of beta-carotene in cultured cells. Mol Aspects Med 2003;24: 353-62.
35. Palozza P, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, et al. Beta-carotene downregulates the steady-state and heregulin-alpha-induced COX-2 pathways in colon cancer cells. J Nutr 2005;135:129-36.
36. Palozza P, Serini S, Di Nicuolo F, Boninsegna A, Torsello A, Maggiano N, et al. Beta-carotene exacerbates DNA oxidative damage and modifies p53-related pathways of cell proliferation and apoptosis in cultured cells exposed to tobacco smoke condensate. Carcinogenesis 2004;25:1315-25.
37. Paolini M, Abdel-Rahman SZ, Sapone A, Pedulli GF, Perocco P, Cantelli-Forti G, et al. Beta-carotene: A cancer chemopreventive agent or a co-carcinogen? Mutat Res 2003;543:195-200.
38. Palli D, Masala G, Peluso M, Gaspari L, Krogh V, Munnia A, et al. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: A study on 634 subjects. Carcinogenesis 2004;25:577-84.
39. Vineis P. Cancer as an evolutionary process at the cell level: An epidemiological perspective. Carcinogenesis 2003;24:1-6.
40. Schatzkin A, Kipnis V. Could exposure assessment problems give us wrong answers to nutrition and cancer questions? J Natl Cancer Inst 2004;96: 1564-5.